Your browser doesn't support javascript.
loading
SARS-CoV-2 Proteins Induce Endotoxin Tolerance Hallmarks: A Demonstration in Patients with COVID-19.
Avendaño-Ortiz, José; Lozano-Rodríguez, Roberto; Martín-Quirós, Alejandro; Maroun-Eid, Charbel; Terrón-Arcos, Verónica; Montalbán-Hernández, Karla; Valentín, Jaime; Muñoz Del Val, Elena; García-Garrido, Miguel A; Del Balzo-Castillo, Álvaro; Casalvilla-Dueñas, José Carlos; Peinado, María; Gómez, Laura; Herrero-Benito, Carmen; Rubio, Carolina; Cubillos-Zapata, Carolina; Pascual-Iglesias, Alejandro; Del Fresno, Carlos; Aguirre, Luis A; López-Collazo, Eduardo.
Afiliación
  • Avendaño-Ortiz J; Innate Immunity Group, Hospital La Paz Institute for Health Research, La Paz University Hospital, Madrid, Spain.
  • Lozano-Rodríguez R; Tumor Immunology Laboratory, Hospital La Paz Institute for Health Research, La Paz University Hospital, Madrid, Spain.
  • Martín-Quirós A; Innate Immunity Group, Hospital La Paz Institute for Health Research, La Paz University Hospital, Madrid, Spain.
  • Maroun-Eid C; Tumor Immunology Laboratory, Hospital La Paz Institute for Health Research, La Paz University Hospital, Madrid, Spain.
  • Terrón-Arcos V; Emergency Department and Emergent Pathology Research Group, Hospital La Paz Institute for Health Research, La Paz University Hospital, Madrid, Spain; and.
  • Montalbán-Hernández K; Innate Immunity Group, Hospital La Paz Institute for Health Research, La Paz University Hospital, Madrid, Spain.
  • Valentín J; Innate Immunity Group, Hospital La Paz Institute for Health Research, La Paz University Hospital, Madrid, Spain.
  • Muñoz Del Val E; Tumor Immunology Laboratory, Hospital La Paz Institute for Health Research, La Paz University Hospital, Madrid, Spain.
  • García-Garrido MA; Innate Immunity Group, Hospital La Paz Institute for Health Research, La Paz University Hospital, Madrid, Spain.
  • Del Balzo-Castillo Á; Tumor Immunology Laboratory, Hospital La Paz Institute for Health Research, La Paz University Hospital, Madrid, Spain.
  • Casalvilla-Dueñas JC; Innate Immunity Group, Hospital La Paz Institute for Health Research, La Paz University Hospital, Madrid, Spain.
  • Peinado M; Tumor Immunology Laboratory, Hospital La Paz Institute for Health Research, La Paz University Hospital, Madrid, Spain.
  • Gómez L; Innate Immunity Group, Hospital La Paz Institute for Health Research, La Paz University Hospital, Madrid, Spain.
  • Herrero-Benito C; Emergency Department and Emergent Pathology Research Group, Hospital La Paz Institute for Health Research, La Paz University Hospital, Madrid, Spain; and.
  • Rubio C; Innate Immunity Group, Hospital La Paz Institute for Health Research, La Paz University Hospital, Madrid, Spain.
  • Cubillos-Zapata C; Innate Immunity Group, Hospital La Paz Institute for Health Research, La Paz University Hospital, Madrid, Spain.
  • Pascual-Iglesias A; Emergency Department and Emergent Pathology Research Group, Hospital La Paz Institute for Health Research, La Paz University Hospital, Madrid, Spain; and.
  • Del Fresno C; Innate Immunity Group, Hospital La Paz Institute for Health Research, La Paz University Hospital, Madrid, Spain.
  • Aguirre LA; Tumor Immunology Laboratory, Hospital La Paz Institute for Health Research, La Paz University Hospital, Madrid, Spain.
  • López-Collazo E; Innate Immunity Group, Hospital La Paz Institute for Health Research, La Paz University Hospital, Madrid, Spain.
J Immunol ; 207(1): 162-174, 2021 07 01.
Article en En | MEDLINE | ID: mdl-34183364

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Límite: Humans Idioma: En Revista: J Immunol Año: 2021 Tipo del documento: Article País de afiliación: España Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Límite: Humans Idioma: En Revista: J Immunol Año: 2021 Tipo del documento: Article País de afiliación: España Pais de publicación: Estados Unidos